Firma büyüme performansının dinamikleri

06.03.2018 tarihli ve 30352 sayılı Resmi Gazetede yayımlanan “Yükseköğretim Kanunu İle Bazı Kanun Ve Kanun Hükmünde Kararnamelerde Değişiklik Yapılması Hakkında Kanun” ile 18.06.2018 tarihli “Lisansüstü Tezlerin Elektronik Ortamda Toplanması, Düzenlenmesi ve Erişime Açılmasına İlişkin Yönerge” gereğince tam metin erişime açılmıştır.Firma büyümesi ülke ekonomisinin sergilediği performansın önemli bir göstergesi olarak kabul edilmektedir. Günümüzün dinamik ve rekabetçi iktisadi ortamında firmaların hayatta kalmaları ve başarıları firma büyümesinin bir zorunluluk olarak değerlendirilme-sini gerektirmektedir. Firmalar açısından büyüme stratejilerinin zamanlaması, doğru büyüme oranı ve büyüme kanalının belirlenmesi oldukça karmaşık organizasyonel değerlendirme süreçlerini içermektedir. Dolayısıyla firma yöneticileri farklı türden zorluklarla karşı karşıya kalmakta ve bu zorluklar çeşitli farklı beceriler gerektirmektedir. Bu çalışmada Türkiye'de sanayi sektöründe faaliyet gösteren firmaların büyüme performansları üzerinde etkili olan temel dinamikler incelenmektedir. Firmalara özgü ayırt edici faktörler bağlamında büyüme olgusunun ele alınmasıyla mukayeseli bir yaklaşım geliştirilmektedir. Firma büyüme performansının çeşitli seviyelerinde büyüme dinamiklerinin etkilerinin analiz edilmesi suretiyle büyüme olgusuna daha kuşatıcı bir yaklaşım geliştirmek amaçlanmaktadır. Firma büyüme performansını etkileyen temel dinamikler çeşitli ekonomik testlere tabi tutularak analiz edilmektedir. Bu çalışma büyüme performansının temel dinamiklerinin firmaları ayırt edici faktörlere göre farklı yapısal özellikler arz ettiğini ve büyüme performansının çeşitli seviyelerinde farklı dinamiklerin etkilerini ortaya çıkarmaktadır. Bu bakımdan başta firmaların büyüme stratejilerinin şekillendirilmesinde olmak üzere devlet kurumlarına, finansal kuruluşlara ve yerel yönetimlere firma büyümesini teşvik edici politika geliştirmede destek sağlayabilecek ampirik bulgular sağlamaktadır.Firm growth is regarded as an important indicator of a country's economic performance. In today's dynamic and competitive economic environment firms' survival and success requires firm growth to be considered indispensable. The timing of growth strategies, determination of the true growth rate and the growth channels involve highly complex organizational assessment processes. Therefore firm managers face different kind of challenges and these challenges require a variety of different set of skills. In this study, the fundamental dynamics affecting the growth performances of the firms operating in Turkish industrial sector are analysed. A comparative approach is developed by examining the firm growth phenomenon within the context of distinguishing firm-specific-factors. An overarching approach to firm growth phenomenon is intended to be developed by analysing the effects of growth dynamics on several levels of the growth rate distribution. Fundamental dynamics of firm growth are analysed by utilizing several econometric models and tests. This study reveals the fact that fundamental growth dynamics affecting firm growth performance display different structural characteristics depending on the firm specific distinguishing factors and that at various levels of firm growth rate distribution different dynamics affect firm growth performance. In this regard, particularly in shaping firm growth strategies, this study provides firms, state institutions, financial institutions and local governments with valuable empirical evidence that may support the development of policies encouraging firm growth activities

Financial Policies of European Union Countries Regarding the Tourism Industry in COVID-19 Process

Purpose – The aim of this study is to examine the financial policies implemented by EU countries in the tourism industry during the COVID-19 process. Design/methodology/approach – The tourism industry has been studied for two reasons. First, the pandemic has significantly affected the tourism industry due to its dynamic structure, which is very quickly affected by crises. The rapid spread of the pandemic through international travel operations has deepened this situation. Second, there are a large number of new entrepreneurs and SME-level enterprises in the tourism industry mostly in need of financial support. In the study, qualitative research methods were used and document analysis was used as a data collection tool. Data on the fiscal and monetary policies implemented by EU countries for the tourism industry during the COVID-19 process were obtained from the United Nations World Tourism Organization (UNWTO). Content analysis was used in the study. The data obtained were analyzed with the help of MAXQDA Qualitative Analysis Program. Findings – According to the results of the study, the financial and monetary policies developed by European Union countries to reduce the impact of COVID-19 on the tourism industry have strong relations with each other. Countries provide support for tourism enterprises to continue their activities. The support given is mainly focused on SMEs. In addition, support is provided to make employment sustainable, liquidity assistance is provided to eliminate cash shortages, especially in credit and employment support Discussion – In fiscal policy, it functions as important in banks as it does in public authorities. Credit, liquidity and tax are the financial instruments most involved in financial policies

The Turkish Version of the Juvenile Arthritis Multidimensional Assessment Report (JAMAR)

The Juvenile Arthritis Multidimensional Assessment Report (JAMAR) is a new parent/patient reported outcome measure that enables a thorough assessment of the disease status in children with juvenile idiopathic arthritis (JIA). We report the results of the cross-cultural adaptation and validation of the parent and patient versions of the JAMAR in the Turkish language. The reading comprehension of the questionnaire was tested in 10 JIA parents and patients. Each participating centre was asked to collect demographic, clinical data and the JAMAR in 100 consecutive JIA patients or all consecutive patients seen in a 6-month period and to administer the JAMAR to 100 healthy children and their parents. The statistical validation phase explored descriptive statistics and the psychometric issues of the JAMAR: the 3 Likert assumptions, floor/ceiling effects, internal consistency, Cronbach\u27s alpha, interscale correlations, test-retest reliability, and construct validity (convergent and discriminant validity). A total of 466 JIA patients (13.7% systemic, 40.6% oligoarticular, 22.5% RF negative poly-arthritis, and 23.2% other categories) and 93 healthy children were enrolled in four centres. The JAMAR components discriminated well-healthy subjects from JIA patients. All JAMAR components revealed good psychometric performances. In conclusion, the Turkish version of the JAMAR is a valid tool for the assessment of children with JIA and is suitable for use both in routine clinical practice and clinical research

Özgün İslami Finansal Kurumlar İnşa Etmek

Özet İslam’ın ruhunun kapitalizmin ruhuyla sert ve keskin bir uyuşmazlık içinde olmasından dolayı, İslam’ın ruhunu ifade etmek üzere tasarlanmış kurumların almış olduğu biçimin de ayrıca farklı olması zorunludur. Kapitalist finansal kurumlar kapitalist toplumların özünde yer alan servet biriktirme sürecini desteklemek üzere tasarlanmışlardır. İslam’da esas olan, kapitalist toplumlarda baskın olanlardan radikal bir şekilde farklı çeşitli hizmet-odaklı kurumlardaki hizmet ruhu ve başkalarına infak etmektir

The Turkish version of the Juvenile Arthritis Multidimensional Assessment Report (JAMAR)

The Juvenile Arthritis Multidimensional Assessment Report (JAMAR) is a new parent/patient reported outcome measure that enables a thorough assessment of the disease status in children with juvenile idiopathic arthritis (JIA). We report the results of the cross-cultural adaptation and validation of the parent and patient versions of the JAMAR in the Turkish language. The reading comprehension of the questionnaire was tested in 10 JIA parents and patients. Each participating centre was asked to collect demographic, clinical data and the JAMAR in 100 consecutive JIA patients or all consecutive patients seen in a 6-month period and to administer the JAMAR to 100 healthy children and their parents. The statistical validation phase explored descriptive statistics and the psychometric issues of the JAMAR: the 3 Likert assumptions, floor/ceiling effects, internal consistency, Cronbach's alpha, interscale correlations, test-retest reliability, and construct validity (convergent and discriminant validity). A total of 466 JIA patients (13.7% systemic, 40.6% oligoarticular, 22.5% RF negative poly-arthritis, and 23.2% other categories) and 93 healthy children were enrolled in four centres. The JAMAR components discriminated well-healthy subjects from JIA patients. All JAMAR components revealed good psychometric performances. In conclusion, the Turkish version of the JAMAR is a valid tool for the assessment of children with JIA and is suitable for use both in routine clinical practice and clinical research

COVID-19 Infection in Peritoneal Dialysis Patients: A Comparative Outcome Study with Patients on Hemodialysis and Patients without Kidney Disease

Objectives: There is limited data about coronavirus disease-19 (COVID-19) characteristics and results in peritoneal dialysis (PD) patients. This study aimed to investigate the characteristics and outcomes among PD patients and compare them with matched hemodialysis (HD) patients and a control group without kidney disease

Impact of hospital-acquired acute kidney injury on Covid-19 outcomes in patients with and without chronic kidney disease: a multicenter retrospective cohort study

Background/aim: Hospital-acquired acute kidney injury (HA-AKI) may commonly develop in Covid-19 patients and is expected to have higher mortality. There is little comparative data investigating the effect of HA-AKI on mortality of chronic kidney disease (CKD) patients and a control group of general population suffering from Covid-19. Materials and methods: HA-AKI development was assessed in a group of stage 3 & ndash;5 CKD patients and control group without CKD among adult patients hospitalized for Covid-19. The role of AKI development on the outcome (in-hospital mortality and admission to the intensive care unit [ICU]) of patients with and without CKD was compared. Results: Among 621 hospitalized patients (age 60 [IQR: 47 & ndash;73]), women: 44.1%), AKI developed in 32.5% of the patients, as stage 1 in 84.2%, stage 2 in 8.4%, and stage 3 in 7.4%. AKI developed in 48.0 % of CKD patients, whereas it developed in 17.6% of patients without CKD. CKD patients with HA-AKI had the highest mortality rate of 41.1% compared to 14.3% of patients with HA-AKI but no CKD (p < 0.001). However, patients with AKI+non-CKD had similar rates of ICU admission, mechanical ventilation, and death rate to patients with CKD without AKI. Adjusted mortality risks of the AKI+non-CKD group (HR: 9.0, 95% CI: 1.9 & ndash;44.2) and AKI+CKD group (HR: 7.9, 95% CI: 1.9 & ndash;33.3) were significantly higher than that of the non-AKI+non-CKD group. Conclusion: AKI frequently develops in hospitalized patients due to Covid-19 and is associated with high mortality. HA-AKI has worse outcomes whether it develops in patients with or without CKD, but the worst outcome was seen in AKI+CKD patients

Determinants of mortality in a large group of hemodialysis patients hospitalized for COVID-19

Background: Maintenance hemodialysis (MHD) patients are at increased risk for coronavirus disease 2019 (COVID-19). The aim of this study was to describe clinical, laboratory, and radiologic characteristics and determinants of mortality in a large group of MHD patients hospitalized for COVID-19

Characteristics and outcomes of hospitalised older patients with chronic kidney disease and COVID-19: A multicenter nationwide controlled study

Objective Older adults with co-morbidities have been reported to be at higher risk for adverse outcomes of coronavirus disease 2019 (COVID-19). The characteristics of COVID-19 in older patients and its clinical outcomes in different kidney disease groups are not well known